FIELD: pharmaceutics.
SUBSTANCE: present group of inventions relates to the field of pharmaceutics, namely to the use of a compound of 3-[(3S,4R)-3-methyl-6-(7H-pyrrolo[2,3-d]pyrimidine-4-yl)-1,6-diazaspiro[3,4]octane-1-yl]-3-oxopropannitrile for the preparation of a drug for the treatment of focal alopecia, as well as to the use of a composition containing the above-mentioned compound as an active ingredient for the preparation of the drug for the treatment of prevention of focal alopecia. In addition, a method for the treatment of focal alopecia in a subject, who needs it, is described, including a stage of injection to the specified subject of therapeutically effective amount of 3-[(3S,4R)-3-methyl-6-(7H-pyrrolo[2,3-d]pyrimidine-4-yl)-1,6-diazaspiro[3,4]octane-1-yl]-3-oxopropannitrile.
EFFECT: providing a new pharmaceutical application of 3-[(3S,4R)-3-methyl-6-(7H-pyrrolo[2,3-d]pyrimidine-4-yl)-1,6-diazaspiro[3,4]octane-1-yl]-3-oxopropannitrile as a therapeutic or preventive agent for focal alopecia.
22 cl, 2 dwg, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF TREATMENT OF PSORIASIS AND OTHER AUTOIMMUNE CONDITIONS USING PRMT5 INHIBITOR | 2021 |
|
RU2803235C1 |
| METHOD FOR PRODUCTION OF 7H-PYRROLO[2,3-D]PYRIMIDINE DERIVATIVES AND THEIR COCRYSTALS | 2017 |
|
RU2779212C2 |
| PRODUCTION METHOD AND INTERMEDIATE PRODUCTS FOR PRODUCTION OF PYRROLO[2,3-D]PYRIMIDINE, AND ITS USE | 2019 |
|
RU2780482C2 |
| TREATMENT OF HYDRADENITIS WITH JAK INHIBITORS | 2020 |
|
RU2805595C1 |
| DERIVATIVES OF AMINOFLUORPIPERIDINE AS A KINASE INHIBITOR | 2018 |
|
RU2762637C1 |
| DERIVATIVES OF OXIFLUOROPIPERIDINE AS A KINASE INHIBITOR | 2018 |
|
RU2758370C1 |
| 5-(7H-PYRROLO[2,3-d]PYRIMIDINE-4-YL)-5-AZASPIRO[2.5]OCTANE-8-CARBOXYLIC ACID DERIVATIVES AS NEW JAK-KINASE INHIBITORS | 2018 |
|
RU2761626C2 |
| PYRAZOLOPYRIMIDINE DERIVATIVES AS A KINASE INHIBITOR | 2017 |
|
RU2714206C1 |
| SUBSTITUTED PURINE AND 7-DEAZAPURINE COMPOUNDS | 2011 |
|
RU2606514C2 |
| PHARMACEUTICAL COMBINATION CONTAINING TNO155 AND RIBOCICLIB | 2020 |
|
RU2813111C2 |
